| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V53298 | (±)-Stylopine hydrochloride (Tetrahydrocoptisine hydrochloride) | 96087-21-7 | (±)-Stylopine (Tetrahydrocoptisine) HCl is an alkaloid compound extracted from the tubers of Corydalis plants. |
|
V19207 | DB03208 (1,2,3,4,6-Pentagalloyl glucose) | 14937-32-7 | Also known as1,2,3,4,6-Pentagalloyl glucose (Penta-O-galloyl-β-D-glucose),DB03208 is a novel and potent inhibitor of receptor tyrosine kinase-like orphan receptor 1 (Ror1),isolated from variousplants. |
|
V123198 | 14-Hydroxydehydroabietane | 67119-95-3 | 14-Hydroxydehydroabietane is a ribosomal enzyme inhibitor. |
|
V112353 | 6-Undecanone | 927-49-1 | 6-Undecanoyl is a ligand for odor-binding protein 22 (OBP22), but its binding affinity is weak. |
|
V104928 | AAP4 | AAP4 is a potent inhibitor of OfChi-h and OfHex1 with Ki values of 29.3 nM and 4.9 μM, respectively. | |
|
V129048 | Anti-infective agent 11 | Anti-infective agent 11 is an orally effective antiparasitic drug. | |
|
V102246 | Antimalarial agent 38 | 123580-46-1 | Antimalarial 38 (Compound 1) is an antimalarial drug that inhibits Plasmodium falciparum D6 strain, chloroquine-sensitive Thai strain, and chloroquine-resistant FcB1 and K1 strains with IC50 of 0.5, 13, 1, and 13 μM, respectively. |
|
V93691 | Antimalarial agent 45 | Antimalarial 45 (Compound 8I) is an antimalarial drug with anti-Plasmodium activity with IC50 of 0.21 μM. | |
|
V129079 | Antimalarial agent 47 | Antimalarial agent 47 is an antimalarial compound with an IC50 of 235 nM against Plasmodium falciparum strain W2. | |
|
V129085 | Antimalarial agent 56 | 1220533-66-3 | Antimalarial agent 56 is an orally effective antimalarial drug. |
|
V129086 | Antimalarial agent 57 | 1258387-40-4 | Antimalarial agent 57 is a quinoline methanol derivative with antimalarial activity. |
|
V102413 | Antiparasitic agent-22 | Antiparasitic agent-22 (compound 24) is a pan-antiparasitic agent that inhibits promastigotes of T. brucei, L. infantum, L. tropica (IC50 of 2.41, 5.95, 8.98 μM), amastigotes of L. infantum (IC50 of 8.18 μM), and Plasmodium falciparum W2 strain (IC50 of 0.155 μM). | |
|
V110876 | Antiparasitic agent-32 | Antiparasitic drug-32 (compound M9) is an analogue of piperaquine and is a potent antiparasitic drug that targets the lactate dehydrogenase (PfLDH) of Plasmodium falciparum (Pf3D7 IC50 = 0.40 μM). | |
|
V96908 | Antiproliferative agent-56 | Antiproliferative agent-56 (compound 31) is an antimalarial drug that inhibits Plasmodium falciparum 3D7 (Pf3D7) with IC50 of >12.5 (48 hours) and 0.03 μM (98 hours) and exhibits slow-acting properties. | |
|
V115073 | Apolactoferrin | Iron-free lactoferrin is an iron-free form of lactoferrin that has antiparasitic activity. | |
|
V117354 | Avermectin A1a | 65195-51-9 | Avermectin A1a is a potent, broad-spectrum antiparasitic drug. |
|
V133421 | Dehydrocorydaline (hydroxyl) | Dehydrocorydaline (hydroxyl) is an alkaloid that regulates the expression of Bax and Bcl-2 proteins; activates caspase-7 and caspase-8; and inhibits PARP. | |
|
V135027 | ELQ-121 | 1228283-36-0 | ELQ-121 is a potent inhibitor of parasitic ubiquinone oxidation (QO) sites. |
|
V116938 | epi-Ivermectin B1a | 2962875-16-5 | Ivermectin B1a is a key related substance of ivermectin, mainly existing as a process-related impurity or potential degradation product in ivermectin antiparasitic formulations. |
|
V106067 | Eprinomectin B1a | 133305-88-1 | Epilinoctin B1a is a metabolite of the antiparasitic compound epilinoctin. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
